Coronary Syndrome Not Yet Recruiting Phase 2 Trials for Rosuvastatin (DB01098)

IndicationStatusPhase
DBCOND0040833 (Coronary Syndrome)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02516826The Effect of Rosuvastatin and Olmesartan on the Progression of Coronary Atherosclerotic DiseaseTreatment